TY - JOUR
KW - Aged
KW - Aged, 80 and over
KW - Cognition Disorders/diagnosis/economics/therapy
KW - Female
KW - Germany
KW - Health Care Costs
KW - Humans
KW - Male
KW - Mental Health Services/economics/utilization
KW - Neuropsychological Tests
KW - Primary Health Care/economics/utilization
KW - Prospective Studies
KW - Questionnaires
AU - M. Luppa
AU - S. Heinrich
AU - H. Matschinger
AU - A. Hensel
AU - T. Luck
AU - S. G. Riedel-Heller
AU - H. H. Konig
A1 - 
AB - BACKGROUND/AIMS: Little is known about the direct costs of individuals with Mild Cognitive Impairment (MCI). This study investigates the direct costs associated with MCI according to recent diagnostic criteria from a societal perspective. METHODS: Four hundred and fifty-two primary care patients aged 75+ from Leipzig, Germany, were investigated in face-to-face interviews regarding MCI according to the current diagnostic criteria of the International Working Group on MCI, resource utilisation and costs (questionnaire of service utilisation and costs), as well as chronic medical illness (Chronic Disease Score). Resource utilisation was monetarily valued using 2004/2005 prices. RESULTS: Mean annual direct costs were 4,443 euro for patients with MCI (n=39) and 3,814 euro for patients without MCI (n=413) (p=0.34). Looking at the cost components, patients with and without MCI only significantly differed regarding pharmaceutical costs (1,210 euro vs 1,062 euro; p<0.05) not caused by antidementive drugs. CONCLUSION: Direct costs of individuals having MCI are not significantly increased in comparison to direct costs of individuals without cognitive deficits.
BT - International journal of geriatric psychiatry
C5 - Financing & Sustainability
CP - 9
CY - England
DO - 10.1002/gps.2018
IS - 9
JF - International journal of geriatric psychiatry
N2 - BACKGROUND/AIMS: Little is known about the direct costs of individuals with Mild Cognitive Impairment (MCI). This study investigates the direct costs associated with MCI according to recent diagnostic criteria from a societal perspective. METHODS: Four hundred and fifty-two primary care patients aged 75+ from Leipzig, Germany, were investigated in face-to-face interviews regarding MCI according to the current diagnostic criteria of the International Working Group on MCI, resource utilisation and costs (questionnaire of service utilisation and costs), as well as chronic medical illness (Chronic Disease Score). Resource utilisation was monetarily valued using 2004/2005 prices. RESULTS: Mean annual direct costs were 4,443 euro for patients with MCI (n=39) and 3,814 euro for patients without MCI (n=413) (p=0.34). Looking at the cost components, patients with and without MCI only significantly differed regarding pharmaceutical costs (1,210 euro vs 1,062 euro; p<0.05) not caused by antidementive drugs. CONCLUSION: Direct costs of individuals having MCI are not significantly increased in comparison to direct costs of individuals without cognitive deficits.
PP - England
PY - 2008
SN - 0885-6230; 0885-6230
SP - 963
EP - 971
EP - 
T1 - Direct costs associated with mild cognitive impairment in primary care
T2 - International journal of geriatric psychiatry
TI - Direct costs associated with mild cognitive impairment in primary care
U1 - Financing & Sustainability
U2 - 18416451
U3 - 10.1002/gps.2018
VL - 23
VO - 0885-6230; 0885-6230
Y1 - 2008
ER -